$0.370
-0.0286 (-7.18%)
At Close: Jun 03, 2026
Here's Why You Should Hold on to NextGen Healthcare Stock Now
02:08pm, Monday, 23'rd Mar 2020
NextGen Healthcare (NXGN) continues to benefit from growing RCM and EHR markets, and robust demand for other NextGen solutions.
Masimo's Latest Buyout to Boost Respiratory Product Spectrum
01:04pm, Friday, 20'th Mar 2020
Masimo (MASI) expects the transaction to be neutral to 2020 earnings.
Masimo's Latest Buyout to Boost Respiratory Product Spectrum
01:04pm, Friday, 20'th Mar 2020
Masimo (MASI) expects the transaction to be neutral to 2020 earnings.
Here's Why You Should Hold Onto Baxter (BAX) Stock for Now
01:50pm, Thursday, 19'th Mar 2020
Baxter (BAX) issues strong guidance for the first quarter of 2020.
Here's Why You Should Hold Onto Baxter (BAX) Stock for Now
01:50pm, Thursday, 19'th Mar 2020
Baxter (BAX) issues strong guidance for the first quarter of 2020.
Accuray Enters Oversold Territory
01:21pm, Thursday, 19'th Mar 2020
Accuray has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Varian's (VAR) ProBeam Compact Treats First Patient at UAB
09:46pm, Wednesday, 18'th Mar 2020
Varian's (VAR) flagship ProBeam platform is seeing multiple developments of late.
Varian's (VAR) ProBeam Compact Treats First Patient at UAB
09:46pm, Wednesday, 18'th Mar 2020
Varian's (VAR) flagship ProBeam platform is seeing multiple developments of late.
NextGen's New Platform Set to Improve Patient Engagement
02:26pm, Wednesday, 18'th Mar 2020
The availability of NextGen's (NXGN) Patient Experience Platform is likely to enable high-quality healthcare and drive patient engagement.
NextGen's New Platform Set to Improve Patient Engagement
02:26pm, Wednesday, 18'th Mar 2020
The availability of NextGen's (NXGN) Patient Experience Platform is likely to enable high-quality healthcare and drive patient engagement.
Baxter (BAX) Q4 Earnings Beat Estimates, Revenues In Line
01:53pm, Tuesday, 17'th Mar 2020
Baxter's (BAX) fourth-quarter earnings benefit from higher revenues, solid segmental performance and growth in APAC.
Baxter (BAX) Q4 Earnings Beat Estimates, Revenues In Line
01:53pm, Tuesday, 17'th Mar 2020
Baxter's (BAX) fourth-quarter earnings benefit from higher revenues, solid segmental performance and growth in APAC.
HealthEquity (HQY) Q4 Earnings and Revenues Top Estimates
12:00am, Tuesday, 17'th Mar 2020Here's Why You Should Hold Onto Varian Medical Stock Now
02:23pm, Monday, 16'th Mar 2020
Varian Medical (VAR) gains from solid prospects of its core Oncology Systems unit.
Sign In
Buy ARAY